{"entity":{"type":"insider","cik":"0001513900","url":"/insider/0001513900","json_url":"/insider/0001513900.json","name":"COLVIN PAUL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2011-05-23","last":"2021-02-03","span_basis":"filed_date"},"name_variants":[{"name":"COLVIN PAUL","source":"filing","n_filings":4,"first_seen":"2011-05-23","last_seen":"2021-02-03"}],"transactions":[{"id":5519368,"accession":"0001209191-21-007350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-007350","line_url":"/filing/0001209191-21-007350#line-1","is_derivative":false,"issuer_cik":"0001513900","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001513900","owner_cik":"0001513900","owner_name":"COLVIN PAUL","owner_display_name":"COLVIN PAUL","owner_url":"/insider/0001513900","role":"Officer (Pres., Clinical Solutions)","role_mark":"O","role_mark_label":"Officer (Pres., Clinical Solutions)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres., Clinical Solutions","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8486.0,"shares_display":"8,486","price_per_share":74.82,"price_display":"74.82","price_state":"stated","total_value":634922.52,"total_display":"634,922.52","total_whole":"634,923","shares_owned_after":28275.0,"shares_owned_after_display":"28,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":2404091,"accession":"0001513900-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001513900-20-000002","line_url":"/filing/0001513900-20-000002#line-1","is_derivative":false,"issuer_cik":"0001513900","issuer_name":"Syneos Health, Inc.","issuer_ticker":"SYNH","issuer_name_source":null,"issuer_url":"/issuer/0001513900","owner_cik":"0001513900","owner_name":"COLVIN PAUL","owner_display_name":"COLVIN PAUL","owner_url":"/insider/0001513900","role":"Officer (Pres., Clinical Solutions)","role_mark":"O","role_mark_label":"Officer (Pres., Clinical Solutions)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres., Clinical Solutions","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":36.65,"price_display":"36.65","price_state":"stated","total_value":47645.0,"total_display":"47,645.00","total_whole":"47,645","shares_owned_after":26855.0,"shares_owned_after_display":"26,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-23","scope":"insider"},{"id":9116585,"accession":"0001513900-11-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001513900-11-000004","line_url":"/filing/0001513900-11-000004#line-5","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001513900","owner_name":"COLVIN PAUL","owner_display_name":"COLVIN PAUL","owner_url":"/insider/0001513900","role":"Officer (EVP--Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP--Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP--Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5659.0,"shares_display":"5,659","price_per_share":28.7,"price_display":"28.70","price_state":"stated","total_value":162413.3,"total_display":"162,413.30","total_whole":"162,413","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-05-27","scope":"insider"},{"id":9116582,"accession":"0001513900-11-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001513900-11-000004","line_url":"/filing/0001513900-11-000004#line-2","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001513900","owner_name":"COLVIN PAUL","owner_display_name":"COLVIN PAUL","owner_url":"/insider/0001513900","role":"Officer (EVP--Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP--Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP--Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":28.7,"price_display":"28.70","price_state":"stated","total_value":2870.0,"total_display":"2,870.00","total_whole":"2,870","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-26","filed_date":"2011-05-27","scope":"insider"},{"id":8970911,"accession":"0001513900-11-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001513900-11-000003","line_url":"/filing/0001513900-11-000003#line-3","is_derivative":false,"issuer_cik":"0001003124","issuer_name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","issuer_ticker":"PPDI","issuer_name_source":null,"issuer_url":"/issuer/0001003124","owner_cik":"0001513900","owner_name":"COLVIN PAUL","owner_display_name":"COLVIN PAUL","owner_url":"/insider/0001513900","role":"Officer (EVP--Clinical Development)","role_mark":"O","role_mark_label":"Officer (EVP--Clinical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP--Clinical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":29.01,"price_display":"29.01","price_state":"stated","total_value":17406.0,"total_display":"17,406.00","total_whole":"17,406","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-20","filed_date":"2011-05-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001610950","name":"Syneos Health, Inc.","url":"/issuer/0001610950","role":"Officer (Pres., Clinical Solutions)","n_filings":2,"first_seen":"2020-03-23","last_seen":"2021-02-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001003124","name":"PHARMACEUTICAL PRODUCT DEVELOPMENT INC","url":"/issuer/0001003124","role":"Officer (EVP--Clinical Development)","n_filings":2,"first_seen":"2011-05-23","last_seen":"2011-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001513900","retrieved_at":"2026-08-23T19:54:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}